Salmaso, S <br/><br/>
Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.  [electronic resource] 

 -  Pediatrics  Nov 2001 
 - E81 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1098-4275 
<br/><br/><label>Standard No.: </label>10.1542/peds.108.5.e81  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Antibodies, Bacterial--blood<br/>Bordetella pertussis--immunology<br/>Child<br/>Child, Preschool<br/>Diphtheria-Tetanus-Pertussis Vaccine--administration & dosage<br/>Diphtheria-Tetanus-acellular Pertussis Vaccines--administration & dosage<br/>Double-Blind Method<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunization Schedule<br/>Immunoglobulin A--blood<br/>Immunoglobulin G--blood<br/>Incidence<br/>Italy--epidemiology<br/>Male<br/>Population Surveillance<br/>Whooping Cough--epidemiology